drugset
drugset / Trial / NCT00772512

A Study Of The Effect Of PF-04802540 On Sleep Measures

NCT00772512 ↗

Phase 1 Completed 13 enrolled Taisho Pharmaceutical Co., Ltd.
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to determine if PF-04802540 decreases REM sleep.

Timeline

Start
2008-11
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-04802540 Unknown 5 mg —
Subject PF-04802540 Unknown 15 mg —

Indications

No indication recorded.